Tech Approach Solves Clinical Trial Document Translation Drift Across EU
Clinical trial sponsors running multi-country studies in the EU face a complex challenge: ensuring translated documents like informed consent forms remain synchronized and approved across different ethics committees. The core problem is version drift, where a change in the master document fails to propagate correctly to all language versions. A proposed technical solution treats the master document as a version-controlled source, with each translation linked to a specific commit via a hash. This creates a single source of truth, allowing automated detection of mismatches between source and translation versions. The method adapts software internationalization pipelines for regulated clinical documentation.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in